Filed: 5/14/2025ACC: 0000950123-25-005195
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $241.72M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$241.72M
Total AUM (reported)
22.11M
Total Shares
Allocation by class
SHS$125.92M52.1%
COM$60.12M24.9%
COM NEW$30.49M12.6%
COM PAR $.01$25.19M10.4%
Portfolio Concentration
Top 3$173.57M71.8%
4–10$41.93M17.3%
11–25$26.22M10.8%
Top 3 weight
71.8%
Top 10 weight
89.2%
Voting Authority Distribution
Total shares with voting rights: 22.11M
Sole
Full voting authority
22.11M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
ROIVANT SCIENCES LTD.
SOLEShares12.48M
TypeSH
Market value$125.92M
52.09%
Sole
12.48M
Shared
0.00
None
0.00
INSMED INC
SOLEShares330.25K
TypeSH
Market value$25.19M
10.42%
Sole
330.25K
Shared
0.00
None
0.00
LIQUIDIA CORPORATION
SOLEShares1.52M
TypeSH
Market value$22.46M
9.29%
Sole
1.52M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS, INC.
SOLEShares1.48M
TypeSH
Market value$8.03M
3.32%
Sole
1.48M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX, INC.
SOLEShares920.20K
TypeSH
Market value$6.75M
2.79%
Sole
920.20K
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS, INC.
SOLEShares878.90K
TypeSH
Market value$6.65M
2.75%
Sole
878.90K
Shared
0.00
None
0.00
NURIX THERAPEUTICS, INC.
SOLEShares447.30K
TypeSH
Market value$5.31M
2.20%
Sole
447.30K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS, INC.
SOLEShares116.36K
TypeSH
Market value$5.24M
2.17%
Sole
116.36K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS, INC.
SOLEShares253.84K
TypeSH
Market value$5.00M
2.07%
Sole
253.84K
Shared
0.00
None
0.00
SCHOLAR ROCK HOLDING CORPORATION
SOLEShares154K
TypeSH
Market value$4.95M
2.05%
Sole
154K
Shared
0.00
None
0.00
DISC MEDICINE, INC.
SOLEShares83K
TypeSH
Market value$4.12M
1.70%
Sole
83K
Shared
0.00
None
0.00
AGIOS PHARMACEUTICALS, INC.
SOLEShares139.73K
TypeSH
Market value$4.09M
1.69%
Sole
139.73K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS, INC.
SOLEShares142.20K
TypeSH
Market value$3.89M
1.61%
Sole
142.20K
Shared
0.00
None
0.00
PHARVARIS N. V.
SOLEShares245.50K
TypeSH
Market value$3.85M
1.59%
Sole
245.50K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS, INC.
SOLEShares2.37M
TypeSH
Market value$3.46M
1.43%
Sole
2.37M
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORPORATION
SOLEShares38.50K
TypeSH
Market value$3.41M
1.41%
Sole
38.50K
Shared
0.00
None
0.00
INTELLIA THERAPEUTICS, INC.
SOLEShares232.78K
TypeSH
Market value$1.66M
0.68%
Sole
232.78K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS, INC.
SOLEShares18.60K
TypeSH
Market value$1.33M
0.55%
Sole
18.60K
Shared
0.00
None
0.00
VYNE THERAPEUTICS INC.
SOLEShares257.03K
TypeSH
Market value$406.1K
0.17%
Sole
257.03K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD.SOLE | SHS | 12.48M | SH | $125.92M 52.09% | 12.48M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 330.25K | SH | $25.19M 10.42% | 330.25K | 0.00 | 0.00 |
LIQUIDIA CORPORATIONSOLE | COM NEW | 1.52M | SH | $22.46M 9.29% | 1.52M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS, INC.SOLE | COM NEW | 1.48M | SH | $8.03M 3.32% | 1.48M | 0.00 | 0.00 |
OCULAR THERAPEUTIX, INC.SOLE | COM | 920.20K | SH | $6.75M 2.79% | 920.20K | 0.00 | 0.00 |
CULLINAN THERAPEUTICS, INC.SOLE | COM | 878.90K | SH | $6.65M 2.75% | 878.90K | 0.00 | 0.00 |
NURIX THERAPEUTICS, INC.SOLE | COM | 447.30K | SH | $5.31M 2.20% | 447.30K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS, INC.SOLE | COM | 116.36K | SH | $5.24M 2.17% | 116.36K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS, INC.SOLE | COM | 253.84K | SH | $5.00M 2.07% | 253.84K | 0.00 | 0.00 |
SCHOLAR ROCK HOLDING CORPORATIONSOLE | COM | 154K | SH | $4.95M 2.05% | 154K | 0.00 | 0.00 |
DISC MEDICINE, INC.SOLE | COM | 83K | SH | $4.12M 1.70% | 83K | 0.00 | 0.00 |
AGIOS PHARMACEUTICALS, INC.SOLE | COM | 139.73K | SH | $4.09M 1.69% | 139.73K | 0.00 | 0.00 |
KYMERA THERAPEUTICS, INC.SOLE | COM | 142.20K | SH | $3.89M 1.61% | 142.20K | 0.00 | 0.00 |
PHARVARIS N. V.SOLE | COM | 245.50K | SH | $3.85M 1.59% | 245.50K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS, INC.SOLE | COM | 2.37M | SH | $3.46M 1.43% | 2.37M | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPORATIONSOLE | COM | 38.50K | SH | $3.41M 1.41% | 38.50K | 0.00 | 0.00 |
INTELLIA THERAPEUTICS, INC.SOLE | COM | 232.78K | SH | $1.66M 0.68% | 232.78K | 0.00 | 0.00 |
SOLENO THERAPEUTICS, INC.SOLE | COM | 18.60K | SH | $1.33M 0.55% | 18.60K | 0.00 | 0.00 |
VYNE THERAPEUTICS INC.SOLE | COM | 257.03K | SH | $406.1K 0.17% | 257.03K | 0.00 | 0.00 |